Company Filing History:
Years Active: 2005-2008
Title: Cécile Combeau: Innovator in Pharmaceutical Chemistry
Introduction
Cécile Combeau is a notable inventor based in Fontenay aux Roses, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of four patents. His work primarily focuses on the development of innovative compounds that serve as kinase inhibitors.
Latest Patents
Cécile Combeau's latest patents include the development of 4-benzimidazol-2-ylpyridazin-3-one derivatives. These compounds are characterized by a general formula where the substituents A, B, D, E, R, and R are defined in detail. The invention also covers the physiologically tolerated salts of these compounds, a process for their preparation, and their application as pharmaceuticals. Notably, these compounds act as inhibitors of the kinase CDK2 (cyclin-dependent kinase 2). Another significant patent involves novel pyridazinone derivatives, which are also aimed at pharmaceutical applications.
Career Highlights
Throughout his career, Cécile Combeau has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma S.A. and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Cécile Combeau has collaborated with notable professionals in his field, including David William Will and Hans Matter. These collaborations have likely enhanced his research and development efforts.
Conclusion
Cécile Combeau is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important kinase inhibitors. His contributions continue to impact the field positively.